肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

发展饮食干预作为癌症的治疗方法

Developing dietary interventions as therapy for cancer

原文发布日期:2022-05-25

DOI: 10.1038/s41568-022-00485-y

类型: Review Article

开放获取: 否

英文摘要:

摘要翻译: 

原文链接:

文章:

发展饮食干预作为癌症的治疗方法

Developing dietary interventions as therapy for cancer

原文发布日期:2022-05-25

DOI: 10.1038/s41568-022-00485-y

类型: Review Article

开放获取: 否

 

英文摘要:

Cancer cells acquire distinct metabolic preferences based on their tissue of origin, genetic alterations and degree of interaction with systemic hormones and metabolites. These adaptations support the increased nutrient demand required for increased growth and proliferation. Diet is the major source of nutrients for tumours, yet dietary interventions lack robust evidence and are rarely prescribed by clinicians for the treatment of cancer. Well-controlled diet studies in patients with cancer are rare, and existing studies have been limited by nonspecific enrolment criteria that inappropriately grouped together subjects with disparate tumour and host metabolic profiles. This imprecision may have masked the efficacy of the intervention for appropriate candidates. Here, we review the metabolic alterations and key vulnerabilities that occur across multiple types of cancer. We describe how these vulnerabilities could potentially be targeted using dietary therapies including energy or macronutrient restriction and intermittent fasting regimens. We also discuss recent trials that highlight how dietary strategies may be combined with pharmacological therapies to treat some cancers, potentially ushering a path towards precision nutrition for cancer.

 

摘要翻译: 

癌细胞根据其组织来源、遗传改变以及与系统性激素和代谢物相互作用程度的不同,会形成独特的代谢偏好。这些适应性变化支撑了癌细胞因生长增殖加速而增加的营养需求。饮食是肿瘤营养的主要来源,然而饮食干预缺乏可靠证据,临床上很少将其用于癌症治疗。针对癌症患者的严格饮食控制研究极为有限,且现有研究受限于非特异性入组标准,不恰当地将具有不同肿瘤和宿主代谢特征的研究对象混为一谈。这种不精确性可能掩盖了饮食干预对适用人群的疗效。本文综述了多种癌症中发生的代谢改变与关键脆弱点,探讨如何通过能量或宏量营养素限制、间歇性禁食等饮食疗法靶向这些脆弱点。我们还讨论了近期临床试验,这些研究揭示了饮食策略与药物治疗相结合治疗某些癌症的潜力,或将为癌症精准营养治疗开辟道路。

 

原文链接:

Developing dietary interventions as therapy for cancer

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……